Literature DB >> 30457024

Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review.

Nadege Wesner1,2, Louis Drevon1,2, Alexis Guedon3, Jean Baptiste Fraison4, Benjamin Terrier5, Salim Trad5, Jean Emmanuel Kahn6, Achille Aouba7, Jerome Gillard8, Matthieu Ponsoye5, Thomas Hanslik5, Clement Gourguechon9, Eric Liozon10, Kamel Laribi11, Julien Rossignol12, Olivier Hermine12, Philippe Seksik13, Lionel Adès14, Fabrice Carrat3, Pierre Fenaux2, Arsène Mekinian1, Olivier Fain1.   

Abstract

We report the 11 cases of +8-MDS/MPN associated with Behcet's-like syndrome and compare them with Behcet's disease and Crohn's disease, pool with literature cases for analysis. Data for patients with +8-MDS/MPN and Behçet's-like syndrome were collected from MINHEMON. Eleven patients had Behcet's-like syndrome and +8-MDS/MPN (median age 75 years [IQR 65-87]; M/F ratio 0.8). MDS and Behcet's-like syndrome were diagnosed at the same time (7/11, 64%). By comparison with 63 patients with idiopathic Behcet's disease without associated MDS, those with Behcet's-like syndrome and +8-MDS/MPN were older (median 75 vs 48 years; p = .0003) and had less pseudofolliculitis (11% vs 62%; p = .0045) and ocular impairment (0% vs 52%; p = .0008), but more frequent gastrointestinal involvement (60% vs 13%; p = .0005). By comparison with Crohn's disease, 39 patients with Behcet's-like syndrome and +8-MDS/MPN were significantly older (median 72 [53-78] vs 36 [27-45] years; p = .0002) and more frequently had oral aphtosis (97% vs 5%, p < .0001), skin features (50% vs 10%, p = .0005) and arthralgia (63% vs 20%, p = .03). Median survival did not differ between patients with Behcet's-like syndrome and +8-MDS/MPN and those with +8-MDS/MPN (n = 103) (47 vs 34 months, p = .61). AML-free survival did not differ between patients with MDS/MPN with and without Behcet's-like syndrome (p = .29). MDS/MPN with trisomy 8 can be associated with particular phenotype of ulcerative digestive disease resembling Behcet's or Crohn's disease and should be considered a single disease.

Entities:  

Keywords:  Behcet’s disease; outcome; treatment; trisomy 8-positive myelodysplastic syndrome

Mesh:

Year:  2018        PMID: 30457024     DOI: 10.1080/10428194.2018.1542152

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  5 in total

1.  Trisomy 8 Associated Clonal Cytopenia Featured With Acquired Auto-Inflammation and Its Response to JAK Inhibitors.

Authors:  Yakai Fu; Wanlong Wu; Zhiwei Chen; Liyang Gu; Xiaodong Wang; Shuang Ye
Journal:  Front Med (Lausanne)       Date:  2022-04-25

Review 2.  Autoimmune Complications in Hematologic Neoplasms.

Authors:  Wilma Barcellini; Juri Alessandro Giannotta; Bruno Fattizzo
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

3.  Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease.

Authors:  Arata Ishii; Shokichi Tsukamoto; Tatsuzo Mishina; Shintaro Izumi; Yurie Nagai; Miki Yamazaki; Yutaro Hino; Kensuke Kayamori; Nagisa Oshima-Hasegawa; Tomoya Muto; Shio Mitsukawa; Yusuke Takeda; Naoya Mimura; Chikako Ohwada; Chiaki Nakaseko; Jun-Ichiro Ikeda; Emiko Sakaida
Journal:  Leuk Res Rep       Date:  2021-10-29

4.  Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.

Authors:  Grégoire Martin de Frémont; Pierre Hirsch; Santiago Gimenez de Mestral; Philippe Moguelet; Yoan Ditchi; Jean-François Emile; Patricia Senet; Sophie Georgin-Lavialle; Thomas Hanslik; François Maurier; Amir Adedjouma; Noémie Abisror; Thibault Mahevas; Florent Malard; Lionel Adès; Pierre Fenaux; Olivier Fain; François Chasset; Arsène Mekinian
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

5.  The acquisition of trisomy 8 associated with Behçet's-like disease in myelodysplastic syndrome.

Authors:  Satoko Oka; Kazuo Ono; Masaharu Nohgawa
Journal:  Leuk Res Rep       Date:  2020-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.